Latest Capital Raising And Funding News

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

White Cliff Minerals has agreed to sell its Great Bear Project in Canada for A$5.8 million, while announcing key board appointments to support its next growth phase.

Intelligent Monitoring Group Limited has significantly reduced its half-year loss while increasing revenue and adjusted EBITDA, driven by organic growth and key acquisitions in Australia and New Zealand.

Tungsten Mining has secured $53 million to push its Mt Mulgine Project through critical feasibility stages while engaging international partners for processing and offtake. The company is positioning itself as a key player in the global tungsten market with strategic moves in the US and Europe.

BPH Energy has successfully raised $0.54 million by issuing over 542 million new listed options, allowing existing option holders to maintain their stake in the company’s future.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

Bellavista Resources Ltd has agreed to acquire up to 80% of the Pickle Crow Gold Project in Ontario, Canada, adding a 2.8 million ounce inferred gold resource at 7.2g/t to its portfolio. The company is raising A$25 million to fund aggressive exploration and development activities.

Mamba Exploration Limited has inked a deal to acquire a majority interest in the underexplored Meeka East Gold Project in Western Australia’s prolific Murchison Goldfield, backed by a $2 million capital raise to fund early-stage exploration.

Mamba Exploration Limited has agreed to acquire a 70% interest in the Meeka East Gold Project in Western Australia’s Murchison Goldfield, supported by a $2 million capital raise to fund exploration activities.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

TradeWindow has launched a NZ$1 million Share Purchase Plan to accelerate its Freight AI operating system development and support growth across Australasia. This follows a successful NZ$5.7 million placement, signalling strong investor confidence in the company’s tech-driven future.

Marquee Resources has reported strong progress on its Mt Clement antimony and gold project with successful Phase 2 drilling and a strategic collaboration for metallurgical testwork, alongside a significant capital raise to fund ongoing exploration.